卡斯特曼病
Castleman Disease.
作者信息
Kaur Harjot, Xiang Zhifu, Kunthur Anuradha, Mehta Paulette
机构信息
is a resident in the Department of Internal Medicine, and and are staff hematologist/oncologists, all at the Central Arkansas Veterans Healthcare System in Little Rock. Dr. Xiang and Dr. Kunthur are assistant professors and Dr. Mehta is a professor in the Division of Hematology/Oncology; all in the Department of Internal Medicine at the University of Arkansas for Medical Sciences in Little Rock.
出版信息
Fed Pract. 2015 Aug;32(Suppl 7):41S-46S.
Abstract
An understanding of the disease pathogenesis has led to the discovery of therapuetic agents that target human herpesvirus-8 replication, CD20, and IL-6 and IL-6R antibodies.
摘要
对该疾病发病机制的了解促使人们发现了针对人类疱疹病毒8型复制、CD20以及白细胞介素6和白细胞介素6受体抗体的治疗药物。
相似文献
1
Castleman Disease.卡斯特曼病
Fed Pract. 2015 Aug;32(Suppl 7):41S-46S.
2
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.类风湿关节炎和Castleman病患者使用抗白细胞介素-6（IL-6）受体抗体托珠单抗后血清白细胞介素-6（IL-6）和可溶性IL-6受体升高的机制及病理意义
Blood. 2008 Nov 15;112(10):3959-64. doi: 10.1182/blood-2008-05-155846. Epub 2008 Sep 10.
3
[Not Available].[无可用内容]
Rev Med Interne. 2022 Dec;43(10S1):10S26-10S33. doi: 10.1016/S0248-8663(23)00022-X.
4
Castleman disease.卡斯特曼病
Curr Opin Hematol. 2007 Jul;14(4):354-9. doi: 10.1097/MOH.0b013e328186ffab.
5
The Role of Interleukin-6 in Castleman Disease.白细胞介素-6在Castleman病中的作用。
Hematol Oncol Clin North Am. 2018 Feb;32(1):23-36. doi: 10.1016/j.hoc.2017.09.003.
6
HIV-associated multicentric Castleman disease.人类免疫缺陷病毒相关多中心性Castleman病
Curr Opin HIV AIDS. 2009 Jan;4(1):16-21. doi: 10.1097/coh.0b013e328319bca9.
7
Multicentric IL-5-positive Castleman Disease With Nephrotic Syndrome Relapsed After Rituximab Treatment.多中心 IL-5 阳性 Castleman 病伴肾病综合征，利妥昔单抗治疗后复发。
In Vivo. 2023 Jan-Feb;37(1):493-497. doi: 10.21873/invivo.13105.
8
Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.卡波西肉瘤疱疹病毒裂解激活的临床表现：多中心性Castleman病（KSHV-MCD）和KSHV炎性细胞因子综合征。
Front Microbiol. 2012 Mar 2;3:73. doi: 10.3389/fmicb.2012.00073. eCollection 2012.
9
Castleman disease and TAFRO syndrome.卡斯尔曼病和 TAFRO 综合征。
Ann Hematol. 2022 Mar;101(3):485-490. doi: 10.1007/s00277-022-04762-6. Epub 2022 Jan 19.
10
Biologic Agents in the Treatment of Multicentric Castleman Disease.生物制剂在多中心Castleman病治疗中的应用
Turk Thorac J. 2018 Oct;19(4):220-225. doi: 10.5152/TurkThoracJ.2018.18066. Epub 2018 Oct 1.
引用本文的文献
1
Atypical Combination of Mixed Connective Tissue Disease and Multicentric Castleman Disease.混合性结缔组织病与多中心Castleman病的非典型组合
Cureus. 2024 Sep 27;16(9):e70325. doi: 10.7759/cureus.70325. eCollection 2024 Sep.
本文引用的文献
1
A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease.一项关于司妥昔单抗（一种抗白细胞介素-6单克隆抗体）在多中心Castleman病患者中安全性的2期开放标签多中心研究。
Oncotarget. 2015 Oct 6;6(30):30408-19. doi: 10.18632/oncotarget.4655.
2
Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease.多中心性Castleman病患者的临床特征及医疗利用情况
Br J Haematol. 2015 Jan;168(1):82-93. doi: 10.1111/bjh.13111. Epub 2014 Sep 11.
3
Use of a claims database to characterize and estimate the incidence rate for Castleman disease.利用索赔数据库来描述和估计卡斯特曼病的发病率。
Leuk Lymphoma. 2015 May;56(5):1252-60. doi: 10.3109/10428194.2014.953145. Epub 2014 Sep 29.
4
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.HHV-8 阴性、特发性多中心 Castleman 病：生物学、发病机制和治疗的新见解。
Blood. 2014 May 8;123(19):2924-33. doi: 10.1182/blood-2013-12-545087. Epub 2014 Mar 12.
5
POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.POEMS 综合征：2014 年诊断、风险分层和治疗更新。
Am J Hematol. 2014 Feb;89(2):214-23. doi: 10.1002/ajh.23644.
6
POEMS syndrome and Castleman disease.POEMS综合征与卡斯特曼病。
Blood. 2013 Jul 11;122(2):159. doi: 10.1182/blood-2013-01-477661.
7
Successful tocilizumab treatment in a patient with human herpesvirus 8-positive and human immunodeficiency virus-negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab-CVP therapy.成功应用托珠单抗治疗人疱疹病毒 8 阳性、人类免疫缺陷病毒阴性、对利妥昔单抗-CVP 治疗无反应的浆细胞型多中心 Castleman 病。
APMIS. 2013 Jul;121(7):668-74. doi: 10.1111/apm.12029. Epub 2012 Nov 20.
8
The clinical spectrum of Castleman's disease.卡斯特曼病的临床谱。
Am J Hematol. 2012 Nov;87(11):997-1002. doi: 10.1002/ajh.23291. Epub 2012 Jul 13.
9
Surgery in Castleman's disease: a systematic review of 404 published cases.Castleman 病的手术治疗：404 例已发表病例的系统回顾。
Ann Surg. 2012 Apr;255(4):677-84. doi: 10.1097/SLA.0b013e318249dcdc.
10
HIV-associated multicentric Castleman disease.HIV 相关多中心 Castleman 病。
Curr Opin Oncol. 2011 Sep;23(5):475-81. doi: 10.1097/CCO.0b013e328349c233.
Zotero 插件